Protein post-translational modifications
RayBiotech Inc. presents the field of protein post-translational modifications (PTMs)
Source: selectscience.net
Post Translational Modifications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Post Translational Modifications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Post Translational Modifications Today - Breaking & Trending Today
Small molecule applications of process Raman spectroscopy
In this interview, Kevin Broadbelt of Thermo Fisher Scientific discusses the small molecule applications of process Raman spectroscopy.
Source: news-medical.net
Pan-cancer studies take pan-oramic view on proteogenomics
The vast variety of tumors makes each cancer a world. For researchers, understanding the commonalities and divergences in their molecular underpinnings could help find successful treatments. Scientists from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) have addressed these similarities and differences in 10 different types of cancer with two proteogenomic studies to unravel the genes that lead to cancer and the galaxy of interactions that regulate them.
Source: bioworld.com
![MyJournals.org - Science - '[ASAP] Assessing Multiple Evidence Streams to Decide on Confidence for Identification of Post-Translational Modifications, within and Across Data Sets' (Journal of Proteome Research) - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
MyJournals.org - Science - '[ASAP] Assessing Multiple Evidence Streams to Decide on Confidence for Identification of Post-Translational Modifications, within and Across Data Sets' (Journal of Proteome Research)
MyJournals.org - Science - '[ASAP] Assessing Multiple Evidence Streams to Decide on Confidence for Identification of Post-Translational Modifications, within and Across Data Sets' (Journal of Proteome Research)
Source: myjournals.org
Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars
CHICAGO, Nov. 22, 2022 /PRNewswire/ -- To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity,
Source: wsiltv.com